ABVX
Abivax S.A.
$139.90
-0.84 (-0.60%)
At close · Jul 10
Market Cap
$12.27B
Shares
87,160,669
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$139.90
Open$140.74
Day$137.72–141.00
52W$8.01–148.83
Avg vol 30d2.9M
Short int4.3M · 5.0% float · 1.5d
Short vol41%
Last earningsDec 31, 2023
DataOct 2023–Jul 2026
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
Equibles Rating
blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical
Buy
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 15 · calm
Equity put/call 0.55
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+23%
above
Price vs 50-day avg
+22%
above
RSI (14)
65
neutral
MACD trend
Positive
52-week position
94%
near high
Volume (OBV)
Bearish div.
distributing
Momentum
relative strength
1-month return
+43%
trailing
6-month return
+20%
trailing
YTD return
+4%
this year
Relative strength
+11%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $115 › 200d $113 — 50d above 200d
Institutional flow
Distributing
11 of 254 funds reported for Jun 30 · net -5.1K sh shares · +3 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
4.96% of float · ▼ -11.5% MoM · 1.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
254 holders — near 2-yr high, broad support
Squeeze score
46
elevated · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
593%
annualized · 1-yr
Max drawdown
−50%
past year
ATR
6.3%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+23%
Bullish
Price vs 50-day avg
+22%
Bullish
RSI (14)
65
Neutral
MACD trend
Positive
Bullish
52-week position
94%
Bullish
Volume (OBV)
Bearish div.
Bearish
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $115 › 200d $113 — 50d above 200d
Institutional flow
Distributing
11 of 254 funds reported for Jun 30 · net -5.1K sh shares · +3 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
4.96% of float · ▼ -11.5% MoM · 1.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
254 holders — near 2-yr high, broad support
Price context
position in its 52-week range
52-wk low $8
Now $140 · 94%
52-wk high $149
vs 200-day avg +23%
vs 50-day avg +22%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ABVX
this stock
Abivax S.A.
|
$12.27B | +3.7% | — | — | 5.0% |
|
ONC
BeOne Medicines Ltd.
|
$431.70B | -1.7% | +22179.2% | 878.5 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$123.19B | +9.5% | +46.2% | 28.8 | 1.9% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$69.63B | -13.8% | +20.8% | 16.2 | 3.3% |
|
ARGX
Argenx SE
|
$54.85B | +8.2% | — | — | 2.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ABVX | -3.3% | +42.7% | +19.8% | +5.0% | +3.7% |
| SPY | +0.8% | +2.0% | +8.9% | +0.7% | +10.2% |
| vs SPY | -4.1% | +40.7% | +10.9% | +4.3% | -6.5% |
Key facts
CIK
1956827
CUSIP
00370M103
13F (30d)
12 filings
12 filers
Visit website
Investor relations